Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
03/12/2009 | US20090069225 Somatostatin analogues |
03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
03/12/2009 | US20090068176 Human neutralizing antibodies aganst hemolytic uremic syndrome |
03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
03/12/2009 | US20090068101 A1 Adenosine Receptor Antagonists |
03/12/2009 | CA2698377A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds for treating fibrosis |
03/11/2009 | EP2033972A1 Screening method for candidate drugs |
03/11/2009 | EP2033953A1 Vanilloid receptor modulators |
03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
03/11/2009 | EP2033651A1 Oxalate-degrading microorganisms or oxalate-degrading enzymes for preventing oxalate related disease |
03/11/2009 | EP2033650A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
03/11/2009 | EP2033644A1 Spiroindene and spiroindane compounds |
03/11/2009 | EP2033634A1 Agent for increasing testosterone level |
03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
03/11/2009 | EP1305409B1 Renal regulatory elements and methods of use thereof |
03/11/2009 | CN101384716A Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
03/11/2009 | CN101384266A Fixed-dose association of phytate and zinc |
03/11/2009 | CN101384261A Method and composition for treating pain |
03/11/2009 | CN101380456A Traditional Chinese medicine for treating infantile bed-wetting |
03/11/2009 | CN101380409A Broadspectrum antiphlogistic traditional Chinese medicine |
03/11/2009 | CN101380365A Baicao Shenqing traditional Chinese medicine composition and preparation method thereof |
03/11/2009 | CN101380121A Preparation method of duck steamed with Jing bamboo |
03/11/2009 | CN100467441C Aminomethyl-phenyl-cyclohexanone derivatives |
03/11/2009 | CN100467035C Medicine for treating frequent micturition and its preparaton method |
03/10/2009 | US7501516 3-Cyanoquinolines 4-substituted by a methylenedioxyphenyl group that is attached by a methylene, oxy, thio, sulfinyl, sulfonyl or amino group; antitumor agents |
03/10/2009 | US7501443 Flavaxate derivatives as muscarinic receptor antagonists |
03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
03/10/2009 | US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
03/10/2009 | US7501115 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
03/10/2009 | CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same |
03/05/2009 | WO2009028618A1 Piperidine derivative |
03/05/2009 | WO2009028543A1 Substituted pyrazole derivative |
03/05/2009 | WO2009027994A2 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
03/05/2009 | WO2009006732A9 Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-msh) and atrial natriuretic protein (anp) and uses in hypertension and acute kidney injury |
03/05/2009 | WO2008108322A3 Composition and method for protecting mitochondria |
03/05/2009 | US20090062398 Deuterium-enriched tolterodine |
03/05/2009 | US20090062387 Method of preventing nephrocalcinosis |
03/05/2009 | US20090062385 Deuterium-enriched fesoterodine |
03/05/2009 | US20090062373 Deuterium-enriched pf-184298 |
03/05/2009 | US20090062345 Amide derivatives as trpv1 antagonists |
03/05/2009 | US20090062133 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
03/05/2009 | US20090060953 Methods for using tetanus toxin for beneficial purposes in animals (mammals) |
03/05/2009 | US20090060944 Enhancer Of The Effect Of Adrenocorticoid,Comprising Gum Arabic |
03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
03/05/2009 | US20090060925 Rage Fusion Proteins and Methods of Use |
03/05/2009 | US20090060922 Acetamide Stereoisomer |
03/05/2009 | CA2697663A1 Substituted pyrazole derivative |
03/05/2009 | CA2696799A1 Piperidine derivative |
03/04/2009 | EP2029617A2 N-oxides of kappa opioid receptor peptides |
03/04/2009 | EP2029134A1 Stabilized pharmaceutical compositions comprising fesoterodine |
03/04/2009 | EP2029131A2 Method for treating renal disease |
03/04/2009 | EP2029128A2 Method of treatment of chronic nonbacterial prostatitis with selective estrogen receptor modulators or aromatase inhibitors |
03/04/2009 | EP1506951B1 Method for the preparation of total salvianolic acid |
03/04/2009 | EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase |
03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
03/04/2009 | EP1455785B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
03/04/2009 | EP1230243B1 Poycyloalkylpurines as adenosine receptor antagonists |
03/04/2009 | EP1140908B1 Triazole compounds with dopamine-d3-receptor affinity |
03/04/2009 | CN101379040A Muscarinic receptor antagonists |
03/04/2009 | CN101378767A Stabilized lanthanum carbonate compositions |
03/04/2009 | CN101376008A Pure medicinal formulation for tonifying kidney and dreplenishing essence and preparation method thereof |
03/04/2009 | CN101375989A Anti-inflammation formulation for treating hyperplastic prostate gland and preparation method thereof |
03/04/2009 | CN101375988A Anti-inflammation formulation for treating acute prostatitis and preparation method thereof |
03/04/2009 | CN101375987A Anti-inflammation formulation for treating chronic prostatitis and preparation method thereof |
03/04/2009 | CN101375858A Solid formulation of urea nitrogen sorbent for compensating kidney function and preparation method thereof |
03/04/2009 | CN100465186C A composition and a method for inhibiting platelet aggregation |
03/04/2009 | CN100465171C A preparation method of potassium sodium dehydroandroan drographolide succinate, a potassium sodium dehydroandroan drographolide succinate preparation and a preparation method thereof |
03/04/2009 | CN100464781C Nutrition liquid for chronic nephropathy and a preparation method thereof |
03/04/2009 | CN100464777C A medicine for treating prostatosis and a preparation method thereof |
03/03/2009 | US7498358 Human ADAM-10 inhibitors |
03/03/2009 | US7498352 TGF-β superfamily production/secretion promoter |
03/03/2009 | US7498335 Method of producing an antiangiogenic or vascular permeability reducing effect |
03/03/2009 | US7498334 Pyrrolopyrimidines as phosphodiesterase VII inhibitors |
03/03/2009 | US7498323 Spiro-piperidine compounds and medicinal use thereof |
03/03/2009 | US7498303 The use of at least one GnRH analogue for the preparation of a medicament for the prevention and/or treatment of side effects of ovarectomy or symptoms associated with reproductive senescence in female mammals, in particular |
03/03/2009 | US7498143 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
03/03/2009 | CA2410880C 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
02/26/2009 | WO2009026517A2 Therapy for complications of diabetes |
02/26/2009 | WO2008022761A3 Rapamycin and its derivatives for the treatment of liver-associated fibrosing disorders |
02/26/2009 | US20090054514 (3-Amino-6-phenyl-benzofuran-2-yl)-(2,4-dichloro-phenyl)-methanone; antiprolifrative, anticarcinogenic, antitumor agent; lymphomas, sarcomas, and leukemias |
02/26/2009 | US20090054495 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis |
02/26/2009 | US20090054480 Novel quinuclidine carbamate derivatives and medicinal compositions containing the same |
02/26/2009 | US20090054462 Hydroisoindoline tachykinin receptor antagonists |
02/26/2009 | US20090054364 treating bladder cancer; transfecting with polynucleotide into urothelial cells; improved transfection efficiency with cationic lipids, cationic polymers or dendrimers; improve drug delivery with a solubilized cholesterol |
02/26/2009 | US20090054341 Methods of Treatment Using Exendin Peptides or GLP-1 Peptides |
02/26/2009 | US20090054336 Binding Agent |
02/26/2009 | US20090054302 Methods and Preparations For Curing Clinically Ill Patients |
02/26/2009 | US20090053805 Post-partum mammalian placenta, its use and placental stem cells therefrom |
02/26/2009 | US20090053231 Optical Disc Apparatus |
02/26/2009 | CA2697057A1 Therapy for complications of diabetes |
02/25/2009 | EP2028187A1 Human and mouse targeting peptides identified by phage display |
02/25/2009 | EP2027872A1 Neurotoxic component of a botulinum toxin for treating a facial disease |
02/25/2009 | EP2027866A1 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
02/25/2009 | EP1878732B1 HIGHLY SELECTIVE Rho-KINASE INHIBITOR |
02/25/2009 | EP1143965B1 Carbocyclic potassium channel inhibitors |
02/25/2009 | CN101374844A Pyrrolopyridazinone compound |
02/25/2009 | CN101372474A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as SSRI |
02/25/2009 | CN101371920A Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin |
02/25/2009 | CN101371908A Gelatin-coated pill for preventing and treating calculi in vivo |